Lunit
- Korean Pharma Earnings Diverge: JW Surges 33% as Huons and Medytox Profits Slide
Second-quarter results split Korea's mid-cap drugmakers: JW Pharmaceutical's profit jumped 32.7% while Huons fell 77.6%, Medytox slipped and Lunit's revenue gre
Second-quarter results split Korea's mid-cap drugmakers: JW Pharmaceutical's profit jumped 32.7% while Huons fell 77.6%, Medytox slipped and Lunit's revenue gre
